Clinical Trial Update: Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating injectable Neucardin for chronic heart failure has completed; no efficacy or safety results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Neucardin (neucardin)

Snippet

Sponsor: Zensun Sci. & Tech. Co., Ltd. | Conditions: Chronic Systolic Heart Failure | Phase 3 | Status: COMPLETED